Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer

It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma
More news in Industry
Central Bank of India Q2 net profit jumps 21% to ₹1,469 crore on higher core income